Myopia Control Efficacy and Long-Term Safety of a Novel Orthokeratology Lens (MESOK Study)—A Randomized Controlled Clinical Trial Combining Clinical and Tear Proteomics Data

Myopia control efficacy and long-term safety of the Breath-O-Correct orthokeratology (OK) lens was evaluated in a 2-year randomized, single vision (SV) spectacle lens-controlled, single-blind clinical trial combining clinical and tear proteomics data. A total of 71 children (43 OK, 9.8 ± 1.3 years;...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Kai Yip, Cheung, Jimmy K. W., Wong, Gigi T. K., Li, Peter H., Chan, Sonia S. H., Lam, Thomas C., Chan, Henry H. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179394/
https://www.ncbi.nlm.nih.gov/pubmed/37176650
http://dx.doi.org/10.3390/jcm12093210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179394/
https://www.ncbi.nlm.nih.gov/pubmed/37176650
http://dx.doi.org/10.3390/jcm12093210

Ejemplares similares